Congratulations to Dr. Jan Piet van Hamburg, PhD candidate Eva Philippon, research technician Lisanne van Rooijen, and Prof. Sander Tas for securing a €425,000 grant from ReumaNederland!
Read more: https://t.co/64QyB9gZJl
A 11-year Dutch study highlights progress and challenges in HIV care for transgender women, with <90% achieving viral suppression. Early diagnosis and community collaboration are key.
Read more: https://t.co/BMJJU9kTQN
@GGDAmsID @HIVMonitoringNL @APH020 @aighd
ADORE unites cancer and neuroscience research at Amsterdam UMC, backed by a €9M @NWONieuws grant to accelerate personalized treatments for cancer, dementia, and MS. #Research#ADORE
Read more: https://t.co/OtyamXJ7Qd
Backed by a €9.5M ZonMw grant, INFECT-NL unites top academic centers, biotech, and global partners to develop vaccines, antibiotics, and pandemic preparedness. After completing a feasibility study, the initiative is now set to move forward.
Read more: https://t.co/PjhChNv3BI
Theo Geijtenbeek and Neeltje Kootstra are working on antiviral strategies to neutralize viruses before they spread. Read more about their TRIM4Health project and how it aims to prevent the next pandemic: https://t.co/rreFsEokSb
#Immunology#Research
@healthholland
@QVQ
Experts recommend a limited vaccination program for the new, more dangerous mpox variant as WHO declares it a global health risk. Prof. de Vries emphasizes the need for vaccination to prevent further spread and protect vulnerable populations.
https://t.co/YcWkzXMQlb
@APH020
Prof.dr. Marjolein Van Egmond received a TKI subsidy of almost €900.000 from @HealthHolland to investigate a new immunotherapeutic approach to treat cancer.
Read more: https://t.co/jW5hi1g8hK
Dr. @MariaThemeli1 will receive a TKI-PPP grant (400K) to develop in collaboration with QVQ Holding BV and dr. @bartwesterman a CAR T cell therapy strategy to treat Glioblastoma (GBM).
Read more: https://t.co/jW5hi1g8hK
A recent study in Science Translational Medicine found that those who had Covid-19 are better protected against other coronaviruses. Dr. Lia van der Hoek discusses the immune response and how adding new proteins to vaccines might enhance protection.
https://t.co/EHWvkgPFOM
It is peak tick season, due to the mild winter and wet spring. @joppehovius professor of infectious diseases at Amsterdam UMC and director of the AI&I research institute, is involved in a large Lyme disease vaccination trial.
Read more: https://t.co/KWd0wfgiRN
A preprint by Amsterdam UMC, @UMCUtrecht, @sanquin, and @VUamsterdam on @biorxivpreprint is receiving exceptional attention.🧬
Why? Discover it in our AI&I news article: https://t.co/pW6fUYsJ9f
🌡️ Rising temperatures mean more hay fever symptoms. Are more people suffering? Prof. Dr. Thomas Rustemeyer of Amsterdam UMC and Maurits van Maaren MSc of Erasmus MC answer the six most common questions. #Allergies#HayFever#Health
https://t.co/YikFVX5mhO
Internist-infectiologist @joppehovius has taken over as the new director of our institute as of January 1st, alongside immunologist @Mebius_Lab, who joined earlier. Learn more about his plans for our research institute: https://t.co/jUdoSGwInN
Dr. @WWalrabenstein, a former finance executive turned health advocate, is revolutionizing aging with a plant-based lifestyle. Her research, "Plants for Joints," unveils the positive impact of plant-based eating on joint health 🌿.
Read more: https://t.co/MeryV8xxSc
Insights from experts, including Dr. Lia van der Hoek, highlight the evolving landscape of SARS-CoV-2. Immunization strategies, including boosters, are crucial amid ongoing vigilance against new variants.
Read more: https://t.co/H4DNeMml8u
#COVID19#pandemic#publichealth
Drs. Renee Schreurs, Carla Ribeiro, and researchers at @AIIresearch
demonstrated a 🛡️ protective role for autophagy in #HIV-1 disease pathogenesis.
💡 Analysis revealed an unidentified polymorphism, which correlated with enhanced survival.
@NatureComms | https://t.co/t2zjRGpI9V
🔍 Contrary to common belief, 4 out of 5 Tuberculosis patients do not exhibit a persistent cough. Read more: https://t.co/bHRr20FIoo
@CobelensFrank@APH020
Dr. Jörg Hamann, head of Amsterdam UMC Biobank, PI at AII, and researcher at @amsneuroscience gets €300,000 MS Research Grant! Project aims to uncover T-cell dynamics in MS lesions. 🧠
Read more: https://t.co/4G2BjZeoNZ
#MultipleSclerosis#Research#Tcell